DHG] has received an unsolicited, non-binding indicative proposal from US-based CoStar Group [NASDAQ:CSGO] to acquire 100% of ...

The Australian market is showing resilience as the ASX200 is set to open slightly higher, even amid global economic concerns ...

The Melbourne-based nuclear medicine company is expected to be a major player in the US radiopharmaceutical market.

Monadelphous has secured new contracts in the resources, energy, and infrastructure sectors valued at $400 million.

Mineral Resources is in only reasonable financial health. Comparatively high current debt levels in conjunction with low lithium prices are somewhat of a concern, though in keeping with Mineral ...

US property giant CoStar has made a $2.7 billion takeover bid for Australia’s second-biggest real estate platform in the ...

Telix Pharmaceuticals 1H25 NPAT up 860% to $49.9m, FY25 revenue guidance of $1.18-1.23bn vs. $1.02bn consensus, R&D ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered ...

On February 20, 2025, CoStar informed Domain that it had acquired 16.9% of Domain’s ordinary shares at $4.20 per share. The implementation of CoStar’s proposal is conditional on CoStar entering into ...

Bell Potter has a buy rating and $27.75 price target on the ASX 200 growth share. This implies potential upside of 13% from ...

Is the Telstra dividend going to continue growing? Let's find out. The post Here's the Telstra dividend forecast through to 2027 appeared first on The Motley Fool Australia.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...